Skip to search formSkip to main contentSkip to account menu

Pumaprazole

Known as: BY841 
An imidazo-pyridine derivative with reversibly binding acid pump antagonist (APA) activity. Contrary to the mechanism of action of the proton pump… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection
Omeprazole produces a higher intragastric pH in the presence of Helicobacter pylori infection than after cure. 
Review
1996
Review
1996
Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Acid-peptic disease is widely considered conquered or controlled, future advances being refinements of existing treatments rather… 
1995
1995
Superior antisecretory profile of the novel reversible gastric proton pump inhibitor BY841, compared to ranitidine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)